Exclusive: How an erosion of staff expertise threatens Makary’s FDA

FDA staff are already missing deadlines, and the future consequences could be even more dire as workers head for the exits.

July 7, 2025 Check out STAT+

Sponsored By

Last chance: Get 50% off a STAT+ annual subscription today and gain access to award-winning journalism, subscriber-only newsletters and email alerts, premium data tools, and event discounts. Thanks for reading!

Jose Luis Magana/AP STAT+ | Inside the staff exodus and tanking morale that threaten Makary's FDA FDA staff are already missing deadlines, and the future consequences could be even more dire as workers head for the exits. By Lizzy Lawrence Leading medical groups sue Kennedy over changed Covid-19 vaccine recommendations Lawsuit says Kennedy's changes are 'contrary to the wealth of data and peer-reviewed studies that demonstrate the safety and efficacy of Covid vaccines' By Chelsea Cirruzzo STAT+ | As Chinese-developed drugs draw U.S. interest, a regulatory chill threatens to dampen new investment A pair of recent announcements by the FDA suggest the agency is focused on national political priorities and has a suspicion of 'hostile countries.' By Brian Yang Adobe STAT+ | Survival rates for cancer patients on immunotherapy depend on insurance coverage, study finds "Health insurance coverage is one of the strongest predictors of access to cancer care and survival following a cancer diagnosis," says study's lead author. By Marissa Russo STAT+ | HHS devises legal playbook for future grant terminations, internal memo shows Guidance from the HHS Office of the General Counsel, obtained by STAT, outlines a new legal advisory process and advice to staffers. By Anil Oza Opinion: Don't let states interfere with medical school grading systems Texas and Indiana have both recently tried to mandate that medical schools use letter grades instead of pass/fail. This student says that's wrong. By Rohit Prasad Nancy Ostertag/Getty Images Opinion: How the U.S. health care system fails cancer patients like former MTV VJ Ananda Lewis Cancer patients like Ananda Lewis turn to "natural therapies" because of fear, confusion, and a sense that no one in the system is looking out for them. By Samyukta Mullangi STAT+ | Apogee reports first data on long-acting eczema drug The antibody treatment alleviated the signs and symptoms of atopic dermatitis far more than a placebo — achieving the efficacy goals of a clinical trial. By Adam Feuerstein

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Daily Recap? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2025, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser